Jennifer Permuth-Wey,Donghwa Kim,Ya-Yu Tsai,Hui-Yi Lin,Y. Ann Chen,Jill Barnholtz-Sloan,Michael J. Birrer,Gregory Bloom,Stephen J. Chanock,Zhihua Chen,Daniel W. Cramer,Julie M. Cunningham,Getachew Dagne,Judith Ebbert-Syfrett,David Fenstermacher,Brooke L. Fridley,Montserrat Garcia-Closas,Simon A. Gayther,William Ge,Aleksandra Gentry-Maharaj,Jesus Gonzalez-Bosquet,Ellen L. Goode,Edwin Iversen,Heather Jim,William Kong,John McLaughlin,Usha Menon,Alvaro N.A. Monteiro,Steven A. Narod,Paul D.P. Pharoah,Catherine M. Phelan,Xiaotao Qu,Susan J. Ramus,Harvey Risch,Joellen M. Schildkraut,Honglin Song,Heather Stockwell,Rebecca Sutphen,Kathryn L. Terry,Jonathan Tyrer,Robert A. Vierkant,Nicolas Wentzensen,Johnathan M. Lancaster,Jin Q. Cheng,Thomas A. Sellers

Supplementary Data and Table 1 from Novel Pheochromocytoma Susceptibility Loci Identified by Integrative Genomics

Supplementary Figures and Tables from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Supplementary Table 2 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Supplementary Table S1 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Data File 3 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Supplementary Table S4 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table S2 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Table S3 from <i>LIN28B</i> Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15Q24-25.1

Supplementary Figures and Tables from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER

Supplementary Methods, Tables 1-4, Figures 1-9 from Identification of <i>Las2</i>, a Major Modifier Gene Affecting the Pas1 Mouse Lung Tumor Susceptibility Locus

Supplementary Data from Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC

Supplementary Data from Genetic Variants That Impact Alternative Polyadenylation in Cancer Represent Candidate Causal Risk Loci

Supplementary Data URL from an Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays

Supplementary Data from Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer

Supplementary Table 1 from An Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens as Potential Immunologic and Clinical Targets in Cancer

Supplementary Tables 1 - 3, Figures 1 - 8 from A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101

Supplementary Tables 1-5 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Tables and Figures from Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators

Supplementary Table 1 from Genetic Variants in the PI3K/PTEN/AKT/mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/Recurrence Risk and Response to Retinoid Chemoprevention